Skip to content

Total debt at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$691.72M+334%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$419K+204%
Pfizer logo
PfizerPFE
Merck & Co. logo
Merck & Co.MRK
AbbVie logo
AbbVieABBV
Insmed logo
InsmedINSM

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.4B+9.7%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Calculated from Innoviva, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s total debt?
Innoviva, Inc. (INVA) reported total debt of $269.43M in Q1 2026.
How has Innoviva, Inc.'s total debt changed year-over-year?
Innoviva, Inc.'s total debt decreased by 40.3% year-over-year, from $451.26M to $269.43M.
What is the long-term trend for Innoviva, Inc.'s total debt?
Over 5 years (2020 to 2025), Innoviva, Inc.'s total debt has grown at a -6.9% compound annual growth rate (CAGR), from $385.52M to $269.02M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.